Perillyl alcohol causes G1 arrest through p15INK4b and p21WAF1/Cip1 induction

被引:24
|
作者
Koyama, Makoto [1 ]
Sowa, Yoshihiro [1 ]
Hitomi, Toshiaki [1 ]
Iizumi, Yosuke [1 ]
Watanabe, Motoki [1 ]
Taniguchi, Tomoyuki [1 ]
Ichikawa, Masami [1 ]
Sakai, Toshiyuki [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan
关键词
perillyl alcohol; G1; arrest; retinoblastoma protein; p15(INK4b); p21(WAF1/Cip1); CELL-CYCLE ARREST; PHASE-II TRIAL; NSC; 641066; INHIBITOR; CANCER; P21; PROTEIN; FAMILY; AGENT;
D O I
10.3892/or.2012.2167
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The monoterpene perillyl alcohol (POH) is a naturally occurring compound derived from citrus fruits, mint and herbs. It exhibited chemotherapeutic potential against various malignant tumors in preclinical models and is currently being tested in clinical trials in patients with refractory advanced cancers. POH inhibits cellular proliferation at the G1 phase of the cell cycle in vitro. However, the molecular mechanisms responsible for this effect have not been sufficiently elucidated. Here we showed that 1.0 mM POH upregulates p15(INK4b) and p21(WAF1/Cip1), resulting in hypophosphorylation of the retinoblastoma (RB) protein and subsequent G1 arrest in human immortalized keratinocyte HaCaT cells. The induction of p15(INK4b) was mediated through its promoter, but that of p21(WAF1/Cip1) was not. The small interfering RNA (siRNA) of either p15(INK4b) or p21(WAF1/Cip1) significantly attenuated the increase in the G1 cell population caused by POH. The induction of p15(INK4b) and p21(WAF1/Cip1) and subsequent G1 arrest by POH was also observed in other cancer cell lines. These results suggest that the induction of p15(INK4b) as well as p21(WAF1/Cip1) is associated with the antiproliferative effect of POH.
引用
收藏
页码:779 / 784
页数:6
相关论文
共 50 条
  • [21] p21B, a variant of p21Waf1/Cip1, is induced by the p53 family
    Susan Nozell
    Xinbin Chen
    Oncogene, 2002, 21 : 1285 - 1294
  • [22] p21B, a variant of p21Waf1/Cip1, is induced by the p53 family
    Nozell, S
    Chen, XB
    ONCOGENE, 2002, 21 (08) : 1285 - 1294
  • [23] P21WAF1/CIP1 protein and tongue cancer prognosis
    Gonzalez-Moles, MA
    Ruiz-Avila, I
    Martinez, JAF
    Gil-Montoya, JA
    Esteban, F
    Gonzalez-Moles, S
    Bravo-Perez, M
    Bascones, A
    ANTICANCER RESEARCH, 2004, 24 (5B) : 3225 - 3231
  • [24] Interferon Regulatory Factor 1 (IRF-1) induces p21WAF1/CIP1 dependent cell cycle arrest and p21WAF1/CIP1 independent modulation of survivin in cancer cells
    Armstrong, Michaele J.
    Stang, Michael T.
    Liu, Ye
    Gao, Jinbo
    Ren, Baoguo
    Zuckerbraun, Brian S.
    Mahidhara, Raja S.
    Xing, Quanhua
    Pizzoferrato, Eva
    Yim, John H.
    CANCER LETTERS, 2012, 319 (01) : 56 - 65
  • [25] Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
    De la Cueva, E.
    Garcia-Cao, I.
    Herranz, M.
    Lopez, P.
    Garcia-Palencia, P.
    Flores, J. M.
    Serrano, M.
    Fernandez-Piqueras, J.
    Martin-Caballero, J.
    ONCOGENE, 2006, 25 (29) : 4128 - 4132
  • [26] Expression of p21WAF1/CIP1 during mouse odontogenesis
    Bloch-Zupan, A
    Leveillard, T
    Gorry, P
    Fausser, JL
    Ruch, JV
    EUROPEAN JOURNAL OF ORAL SCIENCES, 1998, 106 : 104 - 111
  • [27] p21Waf1/Cip1 deficiency stimulates centriole overduplication
    Duensing, Anette
    Ghanem, Louis
    Steinman, Richard A.
    Liu, Ying
    Duensing, Stefan
    CELL CYCLE, 2006, 5 (24) : 2899 - 2902
  • [28] Expression, purification and spectral characterization of p21Waf1/Cip1
    Shi Qiao-yun
    Zheng Yong-chen
    Ren Jin-song
    Qu Xiao-gang
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2008, 24 (02) : 192 - 195
  • [29] A mimic of p21WAF1/CIP1 ameliorates murine lupus
    Goulvestre, C
    Chéreau, C
    Nicco, C
    Mouthon, L
    Weill, B
    Batteux, F
    JOURNAL OF IMMUNOLOGY, 2005, 175 (10): : 6959 - 6967
  • [30] Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
    E De la Cueva
    I García-Cao
    M Herranz
    P López
    P García-Palencia
    J M Flores
    M Serrano
    J Fernández-Piqueras
    J Martín-Caballero
    Oncogene, 2006, 25 : 4128 - 4132